SCHEMBL20871663

SCHEMBL20871663

CC(C)(C)Cc1ccc2c(c1)C(=O)C(Cl)=C(Cl)C2=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
LMNA P02545 4/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
IDO1 P14902 1/20 0.42
DNMT1 P26358 1/20 0.42
DNMT3L Q9UJW3 1/20 0.42
DNMT3A Q9Y6K1 1/20 0.42
ESR1 P03372 1/20 0.38
MITF O75030 1/20 0.38
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CASP3 P42574 2/20 0.37
SENP8 Q96LD8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL899006 0.84 NPC1 (0.65) ALDH1A1LMNANPC1RAB9AMAPT
SCHEMBL23271755 0.77 SMN1; SMN2 (0.47) ALDH1A1LMNANPC1RAB9AMAPT
SCHEMBL20888346 0.76 LMNA (0.46) ALDH1A1LMNANPC1RAB9AMAPT
SCHEMBL28379547 0.76 ALDH1A1 (0.46) ALDH1A1LMNANPC1RAB9AMAPT
SCHEMBL30003171 0.76 ALDH1A1 (0.46) ALDH1A1LMNANPC1RAB9AMAPT
SCHEMBL19879775 0.74 ESR1 (0.41) ALDH1A1LMNANPC1RAB9AMAPT
SCHEMBL9642148 0.71 IDO1 (0.52) ALDH1A1LMNANPC1RAB9AMAPT
SCHEMBL22166505 0.70 ESR1 (0.37) ALDH1A1NPC1RAB9AMAPTL3MBTL1
SCHEMBL22986135 0.70 RAB9A (0.43) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL20052231 0.70 CA1 (0.39) ALDH1A1NPC1RAB9AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11345950-B2 Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same BATTELLE MEMORIAL INSTITUTE (US) 2022-05-31 US disclosed
US-20190100792-A1 PROBE FOR SELECTIVELY CHARACTERIZING ENZYMES INVOLVED IN XENOBIOTIC METABOLISM AND METHOD OF MAKING AND USING THE SAME BATTELLE MEMORIAL INSTITUTE 2019-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345950-B2 Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same CYP2E1, CYP1A1, CYP7A1 ALDH1A1 150/4885LMNA 4217/4885NPC1 1168/4885
US-20190100792-A1 PROBE FOR SELECTIVELY CHARACTERIZING ENZYMES INVOLVED IN XENOBIOTIC METABOLISM AND METHOD OF MAKING AND USING THE SAME CYP2E1, CYP1A1, CYP7A1 ALDH1A1 150/4885LMNA 4217/4885NPC1 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.